Product Serialization to Advance Pharmaceutical Authentication and Patient Safety

In today’s global pharmaceutical distribution environment, the risks to undermine product safety are significant. Counterfeiting and product diversion are major problems and growing. In 2007 the World Health Organization estimated that drug counterfeiting accounted for 1% of sales in developed countries and rose to more than 10% in developing countries. Just a few short years later in 2011, estimates suggested counterfeit drugs can range between 1% to 70% of the total market in developing countries and that even in highly controlled.

Spotlight

Fiocruz

Promote health and social development, generate and disseminate scientific and technological knowledge, be an agent of citizenship. These are the concepts that guide the work of the Oswaldo Cruz Foundation (Fiocruz), linked to the Ministry of Health, the most prominent institution of science and technology in health in Latin America.

OTHER WHITEPAPERS
news image

Ultimate Pharma Messaging Guidebook

whitePaper | March 10, 2023

This pharma messaging guidebook features 20 proven cognitive science techniques that can be used to optimize pharmaceutical claims and messages.

Read More
news image

MEETING CURRENT AND FUTURE SERIALISATIONCHALLENGES

whitePaper | December 5, 2022

Serialisation has emerged as a complex challenge for the pharmaceuticals sector which is facing a multiplicity of differing regulations that vary from one country to another.

Read More
news image

Asia Pacific as a Clinical Trials Powerhouse

whitePaper | October 6, 2022

Patient availability is a critical component for clinical trials, and so it stands to reason that clinical development should match the epidemiology of diseases. Of course, this is often not the case,

Read More
news image

The Annual Clinical Trials Round-up 2021

whitePaper | October 13, 2022

In our previous edition of the Clinical Trials Roundup1, we explored the acute disruptions that the COVID-19 pandemic brought to the clinical trials landscape in 2020.

Read More
news image

The Never-Normal Future of Manufacturing

whitePaper | September 24, 2022

Let’s just say what we’re all thinking: 2020 was rough. It threw pretty much every element of our lives into disarray, and we suddenly had to become experts at navigating a new way of working, schooling and socializing.

Read More
news image

MOLECULAR GLUES LANDSCAPE IN DRUG DISCOVERY

whitePaper | June 21, 2022

nduced-proximity targeted protein degradation (TPD) is a ground-breaking strategy in drug discovery that has emerged during the last decade.

Read More

Spotlight

Fiocruz

Promote health and social development, generate and disseminate scientific and technological knowledge, be an agent of citizenship. These are the concepts that guide the work of the Oswaldo Cruz Foundation (Fiocruz), linked to the Ministry of Health, the most prominent institution of science and technology in health in Latin America.

Events